An analysis, published in BMJ Evidence Based Medicine, looked at clinical trial data on cholesterol lowering drugs and targets for ‘bad’ … read more
A study, published in the BMJ, looked at remdesivir in hospitalised severe COVID-19 patients. Prof Stephen Evans, Professor of Pharmacoepidemiology, … read more
A study, published in Nature, looked at a large-scale screen of potential anti-SARS-CoV-2 drugs. Dr Stephen Griffin, Associate Professor … read more
The UK drug company Synairgen, founded by academics from the University of Southampton, have announced in a press release that … read more
The pharmaceutical company Gilead have released additional data about the drug remdesivir for the treatment of COVID-19, including data on … read more
It has been reported that the US are buying up large stocks of the drug remdesivir, which has preliminarily shown … read more
NHS England have announced that UK patients will be able to access a new treatment for Cystic Fibrosis, combing the … read more
The RECOVERY trial have released a statement on the HIV antiviral drug lopinavir-ritonavir, reporting no clinical benefit hospitalised COVID-19 patients. … read more
A preprint, an unpublished non-peer reviewed study posted to MedRxiv, has looked at the effect of dexamethasone in hospitalised patients … read more
A study, published in the Journal of Clinical Oncology, looked at a new precision medicine, berzosertib, in 40 patients with cancer. … read more
Journalists joined Professor Peter Horby and Professor Martin Landray, Chief Investigators of the RECOVERY trial who provided results on the … read more
The authors of two studies into COVID-19 treatment, published in The Lancet and New England Journal of Medicine (NEJM), have … read more
A Randomised Control Trial (RCT), published in The NEJM, looked at hydroxychloroquine as a treatment for COVID-19. Prof Martin … read more
The World Health Organisation (WHO) has announced that the Executive Group of the Solidarity Trial has endorsed the continuation of … read more
The Lancet have published an expression of concern for a study previously published into hydroxychloroquine and chloroquine in COVID-19 patients. … read more
A press release from the pharmaceutical company Gilead has announced results of stage 3 trial of their antiviral drug remdesivir … read more
The Department of Health and Social Care (DHSC) have announced that remdesivir will be available to some patients via the … read more
The World Health Organisation (WHO) have announced the temporary suspension of a trial into hydroxychloroquine. Prof Peter Horby, Professor … read more
A report, published in the New England Journal of Medicine (NEJM), reports on a trial of remdesivir in patients hospitalised … read more
The pharmaceutical company AstraZeneca, have announced that they have received $1 billion support from US BARDA for the development and … read more
